U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

FDA
Press Announcements
December 3, 2021 – FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

November 30, 2021 – Coronavirus (COVID-19) Update: November 30, 2021

November 30, 2021 – Coronavirus (COVID-19) Update: FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters

 

 

Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee
No meetings on calendar

 

 

::::::

 

White House [U.S.]
Briefing Room – Selected Major COVID Announcements
Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
December 03, 2021 Press Briefings

Remarks by President Biden on the COVID-⁠19 Winter Plan
December 02, 2021 Speeches and Remarks

Background Press Call by Senior Administration Officials on New Actions to Protect Americans Against the Delta and Omicron Variants This Winter
December 02, 2021 Press Briefings

President Biden Announces New Actions to Protect Americans Against the Delta and Omicron Variants as We Battle COVID-⁠19 this Winter
December 02, 2021 Statements and Releases

Statement from White House COVID-⁠19 Response Coordinator Jeff Zients on First Case of the Omicron COVID-⁠19 Variant in the United States
December 01, 2021• Statements and Releases

Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials
November 30, 2021 • Press Briefings

Readout of President Biden’s Meeting with COVID-⁠19 Response Team on the Omicron Variant
November 28, 2021 Statements and Releases

 

 

U.S. Department of State
https://www.state.gov/coronavirus/releases/
Media Notes
Press Statement
Gayle Smith’s Service as the Coordinator for Global COVID-19 Response and Health Security
Antony J. Blinken November 30, 2021